What is the most recent FDA action on file for Becton, Dickinson and Company, BD Biosciences?

July 24, 2024. Argus HQ ingests new FDA enforcement records daily.

Has Becton, Dickinson and Company, BD Biosciences had product recalls?

Yes, 2 recalls on file. See the full history below for each one.

Is this FDA enforcement data for Becton, Dickinson and Company, BD Biosciences official?

Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.

How many FDA actions has Becton, Dickinson and Company, BD Biosciences had?

Argus HQ has recorded 2 FDA events for Becton, Dickinson and Company, BD Biosciences: 0 warning letters, 2 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

FDA Actions Against Becton, Dickinson and Company, BD Biosciences

At a glance: Argus HQ has recorded 2 FDA events for Becton, Dickinson and Company, BD Biosciences: 0 warning letters, 2 recalls, 0 approvals, and 0 inspection 483 observations. These events span from 2024-01-17 to 2024-07-24. The most severe rating Argus HQ has assigned across this history is "high". Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

FDA action counts

Total FDA actions	2
Warning letters	0
Recalls	2
Approval records	0
Form 483 inspection citations	0
Most recent action	July 24, 2024

Risk pattern analysis

Argus HQ analysis — not an FDA finding

This section is Argus HQ analysis, not an FDA finding. Becton, Dickinson and Company, BD Biosciences has 2 separate FDA recalls on file, more than a single isolated recall event. A pattern across multiple FDA touchpoints does not by itself establish that any specific product currently poses a risk; it reflects only the frequency of FDA engagement with this company as recorded in Argus HQ's database. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ does not independently verify FDA's underlying findings; this page summarizes what FDA has published and links back to the original FDA source for each event. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Enforcement history

On 2024-07-24, Argus HQ recorded an FDA recall for Becton, Dickinson and Company, BD Biosciences, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company, BD Biosciences — Class II recall: BD Multitest 6-Color TBNK CE-IVD, REF: 644611; BD Multitest 6-Color TBNK Kit wi…. On 2024-01-17, Argus HQ recorded an FDA recall for Becton, Dickinson and Company, BD Biosciences, rated "high" severity in Argus HQ's classification: Becton, Dickinson and Company, BD Biosciences — Class II recall: CD11b APC: ASR, REF: 340936, and CE, REF: 333143. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures. This page reflects only the FDA event types Argus HQ currently tracks -- FDA Warning Letters, recalls, drug and biologic approvals, and Form 483 inspection observations -- and will update automatically as new FDA records are observed.

Frequently asked questions

What is the most recent FDA action on file for Becton, Dickinson and Company, BD Biosciences?: July 24, 2024. Argus HQ ingests new FDA enforcement records daily.
Has Becton, Dickinson and Company, BD Biosciences had product recalls?: Yes, 2 recalls on file. See the full history below for each one.
Is this FDA enforcement data for Becton, Dickinson and Company, BD Biosciences official?: Every record links directly to its primary FDA.gov source. Argus HQ aggregates and structures public FDA data; the verbatim FDA record is always the source of truth.
How many FDA actions has Becton, Dickinson and Company, BD Biosciences had?: Argus HQ has recorded 2 FDA events for Becton, Dickinson and Company, BD Biosciences: 0 warning letters, 2 recalls, 0 approvals, and 0 Form 483 inspection observations. Argus HQ ingests these records directly from FDA's own public enforcement and approval databases rather than from company disclosures.

Every FDA action tied to this company, the week it happens.

Free weekly briefing. Real-time alerts on paid plans.

Compare with

Two different companies merged onto this page by mistake? Or a name variant missing? Tell us — corrections@argushq.ai

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Verified from FDA.gov · Last updated: Jul 24, 2024

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2024). FDA Actions Against Becton, Dickinson and Company, BD Biosciences. Digital Empire LLC. Retrieved from https://argushq.ai/company/becton-dickinson-and-company-bd-biosciences

MLA

"FDA Actions Against Becton, Dickinson and Company, BD Biosciences." Argus HQ Research, Digital Empire LLC, 2024, argushq.ai/company/becton-dickinson-and-company-bd-biosciences.

Chicago

Argus HQ Research. "FDA Actions Against Becton, Dickinson and Company, BD Biosciences." Digital Empire LLC. Accessed July 17, 2026. https://argushq.ai/company/becton-dickinson-and-company-bd-biosciences.

BibTeX

@misc{argushq_argushq_ai_company_becton_dickinson_and_company_bd_biosciences_2024,
  title = {FDA Actions Against Becton, Dickinson and Company, BD Biosciences},
  author = {{Argus HQ Research}},
  year = {2024},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/company/becton-dickinson-and-company-bd-biosciences},
  note = {Accessed: July 17, 2026}
}

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗